Shaikh Mohammed Ishaque A Hamid1*, Akhtar Husain Farooqui2
1Department of Medicine, Z.V.M. Unani Medical College & Hospital, Pune, Maharashtra, India.
2Department of Medicine, Z.V.M. Unani Medical College & Hospital, Pune, Maharashtra, India.
ORIGINAL RESEARCH ARTICLE
Volume 4, Issue 1, Page 15-21, January-April 2016.
Article history
Received: 09 February 2016
Revised: 12 March 2016
Accepted: 20 March 2016
Early view: 25 March 2016
*Author for correspondence
E-mail: [email protected]
ABSTRACT
Background: The aim of the present study is to evaluate the efficacy of Safoof-e-ajwain in the management of shara (Urticaria).
Materials & Methods: All the patients received same dosage of Unani drug for decided period. 37 patients were enrolled in the study (26 Males and 11 Females). 30 patients (19 males & 11 females) completed the study & 7 patients were lost to follow-up. Thirty patients, aged between 20 to 60 years, of either sex (who attended the outpatient department, with clinical evidence of Shara (Urticaria) were included in the study. BSL-Random was done on first day of visit before starting the medicine. The cases received Safoof-e-ajwain 10.5 grams orally for 45 days. The patients were followed every 15 days for the period of 45 days. Clinical evaluations were done. Statistical analysis was done.
Results: The average UAS score is significantly higher at visit 1 compared to visit 2 UAS score (P-value<0.05). The average UAS score is significantly higher at visit 1 compared to visit 3 UAS score (P-value<0.001). The mean % reduction in UAS score at visit 3 was 25.61% compared to the UAS score at visit 1. The average UAS score is significantly higher at visit 1 compared to visit 4 UAS score (P-value<0.001). The mean % reduction in UAS score at visit 4 was 35.96% compared to the UAS score at visit 1.
Background: The aim of the present study is to evaluate the efficacy of Safoof-e-ajwain in the management of shara (Urticaria).
Materials & Methods: All the patients received same dosage of Unani drug for decided period. 37 patients were enrolled in the study (26 Males and 11 Females). 30 patients (19 males & 11 females) completed the study & 7 patients were lost to follow-up. Thirty patients, aged between 20 to 60 years, of either sex (who attended the outpatient department, with clinical evidence of Shara (Urticaria) were included in the study. BSL-Random was done on first day of visit before starting the medicine. The cases received Safoof-e-ajwain 10.5 grams orally for 45 days. The patients were followed every 15 days for the period of 45 days. Clinical evaluations were done. Statistical analysis was done.
Results: The average UAS score is significantly higher at visit 1 compared to visit 2 UAS score (P-value<0.05). The average UAS score is significantly higher at visit 1 compared to visit 3 UAS score (P-value<0.001). The mean % reduction in UAS score at visit 3 was 25.61% compared to the UAS score at visit 1. The average UAS score is significantly higher at visit 1 compared to visit 4 UAS score (P-value<0.001). The mean % reduction in UAS score at visit 4 was 35.96% compared to the UAS score at visit 1.
Conclusion: Shara (Urticaria) occurred in different religions of people mostly in Upper middle class. Majority of thin patients followed by fatty & broad type of physique had Shara (Urticaria). Males & females of 3rd decade of life having prevalence of allergy was present in majority of cases. In patients of Shara (Urticaria) poor appetite was present. Urticarial patients had no addiction except very few.
Keywords: Urticaria, Safoof-e-Ajwain, Management, Shara, Allergy.
Keywords: Urticaria, Safoof-e-Ajwain, Management, Shara, Allergy.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.